Fritextsökning
Innehållstyper
-
TdB Consultancy AB
-
The government proposes fines for pharmaceutical companies that fail to notify drug shortages in time
According to a compilation from the Swedish Medicines Agency, the number of residually notified medicines increased by 54 % in Sweden last year compared to the ...
-
He saved lives with his theories – was ostracised and ended up in a mental hospital
Hungarian doctor Ignaz Semmelweis (1818-1865) undoubtedly possessed plenty of persistence, diligence and sound reasoning skills – but he was hardly blessed with...
-
A new malaria vaccine offers hope but much more research is still needed
There has long been no vaccine against malaria, but there have been breakthroughs in recent years. However, it is still unclear how we become immune to the mala...
-
Han blir ny nordisk chef på Becton Dickinson
Det amerikanska medicinteknikbolaget Becton Dickinson and Company (BD) har anställt en ny nordisk chef, Hans Braunstein.
-
A world-class research village
Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life sci...
-
Internationella vaccininstitutets kontor i Sverige växer
Internationella vaccininstitutets kontor i Stockholm har nu funnits i över ett år. Under året som gått har utbildningar och projekt dragits i gång, berättar Anh...
-
Ny vd för Mediq
Shahram Khorsand efterträder Gunilla Rittgård som vd för Mediq Sverige .
-
Han får ny roll på Amgen Sverige
Amgen Sverige har utsett Ola Gelin till ansvarig för digital utveckling och extern kommunikation.
-
Ny vd på Aegirbio
Diagnostikbolaget Aegirbio har rekryterat en ny vd – Marco Witteveen.
-
Individual DNA passport could result in fewer drug side effects
You may be required to show a DNA passport when you pick up medicines at the pharmacy in the future. According to a new study, patients might suffer 30% fewer s...
-
The first Lyme disease vaccine faces a delay
Pfizer and Valneva’s Lyme disease vaccine, which could be the first of its kind, is facing delays of about a year. The reason is problems at trial sites in the ...
-
Novo Nordisk sues compounding pharmacies in the US
Novo Nordisk is suing compounding pharmacies in Florida, USA, because the company claims to have found impurities in the active ingredient in the obesity drug Wegovy.
-
Nya namn förstärker Cerenos ledningsgrupp
Cereno Scientific utökar sin ledningsgrupp med två personer: nyrekryterade CMO:n Rahul Agrawal samt affärsutvecklingschefen Julia Fransson.
-
WHO utfärdar globalt nödläge efter mpox-utbrott
Världshälsoorganisationen WHO har återigen utlyst globalt nödläge på grund spridningen av mpox, tidigare kallat apkoppor.
-
Jättestudie: Storpratare i mobilen löper inte större risk för hjärntumör
En stor studie med över en kvarts miljon deltagare fann inget samband mellan långvarig mobiltelefonanvändning och risken för hjärntumör.
-
The stomach medication that became the biggest blockbuster of the 1990s
The omeprazole molecule was synthesised as early as 1979, but it took many years before the then Astra had an approved pharmaceutical. Once this happened, a tab...
-
Ziccum får ny CFO
Frida Hjelmberg börjar som CFO den 1 januari 2021.
-
Skräpmat gav råttor dåligt minne
Råttor som kalasar på fett och socker i ung ålder kan drabbas av varaktiga minnesstörningar, enligt en ny amerikansk studie.
-
Great Swedish innovations: Eye treatment became a feather in Pharmacia’s cap
From complicated and sometimes risky surgery to a routine procedure. Pharmacia’s injectable Healon revolutionised the field of eye surgery - and is considered b...
-
“We are Europe’s hotspot in life science”
The Medicon Valley Alliance has worked for competence development in life science in Denmark and Sweden for a quarter of a century. Anette Steenberg, CEO, sees ...
-
New study: Post-Covid symptoms are common even after mild Covid-19
According to researchers at the University of Gothenburg, loss of smell and taste, shortness of breath and chest symptoms are the most common complaints after a...
-
Ny CBO hos Bioinvent
Cancerforskningsföretaget Bioinvent har rekryterat Sylvie Ryckebusch till rollen som Chief Business Officer.
-
Pharma-on-Demand
Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...